Skip to Main Content

Avera St. Luke's

  • Quality Indicators - Avera St. Luke's (Heart Failure)

Quality Reporting - Avera St. Luke's

Heart Failure

Heart Failure, sometimes called congestive heart failure, is a chronic (long-term) condition caused by the inability of the heart to pump as much blood as the body needs. Heart failure becomes more common with age and causes symptoms such as shortness of breath and a build-up of fluid in the feet and legs. Heart failure is one of the most common reasons for hospitalization. A healthy lifestyle and proper medications can reduce the effects of heart failure and the need for future hospitalization. These indicators examine how well we manage the care of patients hospitalized for heart failure. 

April 2009 - June 2009

Heart Failure - Discharge Instructions

Number of heart failure patients and/or their caregiver per 100 patients, who received written instruction or educational material at discharge addressing all of the following:  activity level, diet, discharge medications, follow-up appointment, weight monitoring, and what to do if symptoms worsen. Patients who do not understand or follow discharge instructions are often re-hospitalized.
  
Technical  
Includes inpatients discharged with a principal diagnosis of heart failure and discharge to home. Excludes patients less than 18 years of age. 

Area/Measure Avera Facility HQID Ranking HQID Median HQA Median/ Average
25 patients discharged; 24 received discharge instructions 96% 91.62%

NA

 
Heart Failure - Evaluation of LVS Function

Number of heart failure patients per 100, with documentation that left ventricular systolic function (LVS) was assessed (test performed to determine if left ventricle of the heart is performing effectively) before arrival, during hospitalization, or is planned following discharge. Identification of patients
with LVS is important to the evaluation and management of heart failure patients.  
  
Technical  
Includes inpatients discharged with a principal diagnosis of heart failure. Excludes patients transferred to another hospital, patients who died or left AMA, and patients with reasons documented for no LVS assessment.

Area/Measure Avera Facility HQID Ranking HQID Median HQA Median / Average

42 patients discharged; 41 received LVS Assessment

97.62% 100%

NA

 
Heart Failure - ACEI or ARB for LVSD
Number of heart failure patients with left ventricular systolic dysfunction (LVSD), a particular form of heart failure, per 100, who received an angiotensin converting enzyme inhibitor (ACEI) or an angiotensin receptor blocker (ARB), a class of drugs used in the treatment of heart failure, at hospital discharge. ACEI therapy improves the survival of heart failure patients. Recent medical recommendations also include angiotensin II receptor blocker (ARB) therapy, and patients given ARBs will be counted as meeting this indicator, starting with 2005 discharges.  
  
Technical  
Includes inpatients discharged with a principal diagnosis of heart failure and with moderate to severe systolic dysfunction. Excludes patients with contraindications to ACEI, patients transferred to another acute care hospital, patients who died or left AMA, and patients discharged to hospice.

Area/Measure

Avera Facility HQID Ranking

HQID Median

HQA Median/ Average
1 patient discharged; 1 patient received ACEI or ARB 100% 100%

NA

 
Heart Failure - Adult Smoking Cessation Advice/Counseling
Number of heart failure patients who smoke per 100, who received smoking cessation counseling in the hospital. Smoking increases the risk of heart failure.  
  
Technical  
Includes inpatients discharged with a principal diagnosis of heart failure and history of smoking within the prior year. Excludes patients transferred to another hospital, patients who died or left AMA, and patients discharged to hospice.
Area/Measure Avera Facility HQID Ranking HQID Median HQA Median / Average
4 patients discharged; 4 patients received smoking cessation advice 100% 100%

NA